Celebrating 25+ years of helping you give wisely
America's most independent,
assertive charity watchdog
Top Rated

EngenderHealth

CharityWatch report issued
October 2018

Top-Rated Charity
A
CharityWatch Grade
Our independent grade based
on a number of factors.
 
84%
Program Percentage
Amount spent on programs
relative to overhead.
 
$2
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

EngenderHealth
505 9th Street, NW
Suite 601
Washington, DC, 20004

Other Names

None

Tax Status

501(c)3

Stated Mission

To improve the health and well-being of people in the poorest communities of the world by sharing expertise in sexual and reproductive health and transforming of the quality of health care.

View similar charities
Data based on Fiscal Year Ended 06/30/2017

Program Percentage: 84%

The percentage of EngenderHealth 's cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).

$62,000,000

Calculated Total Expenses

(rounded)

 

Cost to Raise $100: $2

How many dollars EngenderHealth spends on fundraising to raise each $100 of contributions.

$31,000,000

Calculated Total Contributions

(rounded)

Government Funding

50% to 100%

Percentage of cash revenue
coming from government sources

 

Financial Documents

Entity Document Type Tax ID
EngenderHealth IRS Form 990 13-1623838
EngenderHealth Audited Financial Statements 13-1623838
Entity: EngenderHealth
Document Type: IRS Form 990
Tax ID: 13-1623838
Entity: EngenderHealth
Document Type: Audited Financial Statements
Tax ID: 13-1623838

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
This charity is Top-Rated
What does it mean to be Top-Rated?
 
EngenderHealth
meets governance benchmarks.
 
EngenderHealth
meets transparency benchmarks.
Transparency
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy

  Name Title Compensation
1 Richard Killian Project Director $348,270
2 Gary Camus CFO $298,534
3 Paul Perchal VP $266,092
1
Name: Richard Killian
Title: Project Director
Compensation: $348,270
2
Name: Gary Camus
Title: CFO
Compensation: $298,534
3
Name: Paul Perchal
Title: VP
Compensation: $266,092

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.
According to the EngenderHealth audit of June 30, 2017 (Note 3, Concentration of Credit Risk):

"... Total contributions and private grants revenue received from one donor aggregate to 78% and 42% during 2017 and 2016, respectively..."
According to the EngenderHealth audit of June 30, 2017 (Note 11(b), Commitments and Contingencies):

"EngenderHealth receives funding from U.S government agencies, primarily USAID, and other organizations for various activities which are subject to audits. Although such audits may result in disallowance of certain expenditures, which would be absorbed by EngenderHealth, in management's opinion, the ultimate outcome of such audits would not have a material effect on the financial position, changes in net assets, or cash flows of EngenderHealth.

"At June 30, 2017, accounts payable and accrued expenses...include reserves totaling $270,965, which represent management's estimate of amounts related to an ongoing audit and notice of disallowance on its Kenya/APHIA project. In April 2013, EngenderHealth received a revised audit report commissioned by USAID Kenya regarding the Kenya/APHIA project indicating questioned costs totaling $1,362,121. EngenderHealth submitted a formal response to the original audit report on August 3, 2013 stating their position that the questioned costs were principally allowable. On February 28, 2014, the USAID/Kenya Agreement Officer issued a Final Decision to sustain the full amount of $1,362,121 as disallowed. On March 28, 2014, EngenderHealth submitted a formal appeal of the Final Decision to USAID/Washington, contesting $1,253,297 of the disallowance and conceding a disallowance of $108,824. As of June 30, 2017 EngenderHealth continues to believe that it has made adequate provisions for the liabilities likely to arise although the ultimate liability is dependent upon the outcome of the agreement with the relevant authority or litigation where appropriate."

Related Articles

No related articles found